The outbreak of the novel coronavirus pneumonia has spread rapidly worldwide, which has caused a great impact on the production and supply chain of drugs. Some countries have reflected the tight supply of raw materials.The head of the Ministry of industry and information technology said that since this year, China's API exports have declined year-on-year, with most products falling by 10% to 20%, but there are also a few varieties of exports rising year-on-year. International transportation has become a bottleneck restricting the export of APIs.
Insiders believe that the recovery rate of API enterprises has steadily increased, and domestic demand has been basically met. It is expected to meet overseas demand, and the export of epidemic related APIs may usher in a short period of outbreak. However, it should be noted that due to the postponement of non anti epidemic medical demand, if the foreign pharmaceutical industry is suspended for a long time, it will have a negative impact on China's API exports as a whole.